Clinical Characteristics of Alternaria Keratitis

Table 1

Clinical data of patients with Alternaria keratitis.

Patient	Risk factors	Location and size	Medical treatment	Surgery	Initial VA	Final VA	F/U (months)	Others
1	Trauma	C, 4×3 mm	Natamycin + Amphotericin B		CF	20/200	2
2	Trauma	C, 2×2 mm	Amphotericin B		20/200	20/100	10
3	Unknown, DM	C, 4×4.4 mm	Natamycin + amikacin + ciprofloxacin	Superficial keratectomy	20/200	20/70	16	(i) Cataract operation 1 month ago; (ii) A farmer; (iii) Coinfection with M.chelonae
4	Trauma	C, 3.6×3 mm	Natamycin	Superficial keratectomy, patch graft	CF	20/200	15	PKP + ECCE + IOL 5; months later
5	Trauma	C, 3×4 mm	Natamycin		CF	20/100	29
6	Trauma	C, 2×2 mm	Natamycin + amphotericin B		20/400	20/100	4
7	SCL	P, 1×1 mm	Cefazolin + amikacin		20/25	20/20	2

DM: diabetes mellitus, SCL: soft contact lens, C: central, P: peripheral, CF: counting fingers, F/U: follow-up, PKP: penetrating keratoplasty, ECCE: extracapsular cataract extraction, and IOL: intraocular lens.